Prostate cancer-associated SPOP mutants (Y87C, Y87N, F102C, S119N, F125V, W131G, F133L, and F133V) fail to bind AR protein, thereby increasing the protein stability and activity of AR during tumorigenesis (96, 100). Here, SPOP is linked to prostate carcinoma.